They have a plan! Part of message received today f
Post# of 148163
Quote:
We formed the committee because we see the potential of Leronlimab and believe the world needs and deserves access to this molecule. Our most pressing goal is to gain FDA approval for Leronlimab and start generating much-needed revenue for CytoDyn. We will achieve that with a phase 3 long hauler study. More details to follow, but we have had discussions with the FDA and have incorporated their advice into the trial protocol, which has been written and is ready to be filed. Other goals are fixing the beleaguered HIV BLA and focusing the oncology effort on individual cancers which have the highest expression of CCR5.
The most disturbing part is the statement that they have had conversations with the FDA. How can that even occur??? Either a lie or potential a breach of ethics with the FDA?
CytoDyn Inc (CYDY) Stock Research Links
Lamont
#1 30.58333 114.26667
#2 39.002744, -77.103470